915095-99-7 ((1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇,Peracetyl Empagliflozin)

CAS号:
915095-99-7
中文名称:
(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇
英文名称:
Peracetyl Empagliflozin
分子式:
C31H35ClO11
分子量:
619.056009531021

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)名称与标识符

名称

中文别名:
(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;乙酰恩格列净;
英文别名:
(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol;Acetoxy Empagliflozin;BCP17275;[(2R,4R)-3,4,5-Triacetyloxy-6-[4-chloro-3-[[4-(oxolan-3-yloxy)phenyl]methyl]phenyl]oxan-2-yl]methyl ;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, tetraacetate, (1S)- (9CI);Peracetyl Empagliflozin;PeracetylEmpagliflozin;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]-phenyl]methyl]phenyl]-, 2,3,4,6-tetraacetate, (1S);D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, 2,3,4,6-tetraacetate, (1S)-;915095-99-7;BS-51344;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, tetraacetate, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucito;ZB1712;(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-te; Trahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate;[(2R,3R,4R,5S,6S)-3,4,5-Triacetyloxy-6-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]oxan-2-yl]methyl acetate;D5AR7LVU55;F71486;Peracetyl Empagliflozin; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, 2,3,4,6-tetraacetate, (1S)- (ACI); D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, tetraacetate, (1S)-;(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;SCHEMBL1714371;

标识符

InChIKey:
IVTYEGRDCQLUJE-WYRGLLQMSA-N
Inchi:
1S/C31H35ClO11/c1-17(33)38-16-27-29(39-18(2)34)31(41-20(4)36)30(40-19(3)35)28(43-27)22-7-10-26(32)23(14-22)13-21-5-8-24(9-6-21)42-25-11-12-37-15-25/h5-10,14,25,27-31H,11-13,15-16H2,1-4H3/t25?,27-,28?,29?,30?,31+/m1/s1
SMILES:
ClC1C=CC(=CC=1CC1C=CC(=CC=1)OC1COCC1)C1C([C@H](C([C@@H](COC(C)=O)O1)OC(C)=O)OC(C)=O)OC(C)=O

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)物化性质

计算特性

  • 精确分子量 : 618.1867896g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 11
  • 可旋转化学键数量 : 14
  • 同位素质量 : 618.1867896g/mol
  • 重原子数量 : 43
  • 复杂度 : 967
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 6
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.8
  • 拓扑分子极性表面积 : 133

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)安全信息

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)推荐厂家 更多厂家(72)

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)合成路线

合成路线:1 步
反应条件:
参考文献:
A Metal-Free Direct Arene C-H Amination
Wang, Tao; Hoffmann, Marvin; Dreuw, Andreas; Hasagic, Edina; Hu, Chao; et al, Advanced Synthesis & Catalysis, 2021, 363(11), 2783-2795
合成路线:1 步
反应条件:
参考文献:
Efficient Synthesis of Empagliflozin, an Inhibitor of SGLT-2, Utilizing an AlCl3-Promoted Silane Reduction of a β-Glycopyranoside
Wang, Xiao-jun; Zhang, Li; Byrne, Denis; Nummy, Larry; Weber, Dirk; et al, Organic Letters, 2014, 16(16), 4090-4093

(1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇(915095-99-7)参考资料

Reaxys RN:
PubChem CID: